Reply to 'Rituximab in CD20 positive multiple myeloma' by P Moreau et al. [10]

P. T. Greipp; P. Kapoor; W. G. Morice; T. E. Witzig; P. R. Greipp

doi:10.1038/sj.leu.2404972

Reply to 'Rituximab in CD20 positive multiple myeloma' by P Moreau et al. [10]

P. T. Greipp, P. Kapoor, W. G. Morice, T. E. Witzig, P. R. Greipp

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	214-215
Number of pages	2
Journal	Leukemia
Volume	22
Issue number	1
DOIs	https://doi.org/10.1038/sj.leu.2404972
State	Published - Jan 2008

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/sj.leu.2404972

Cite this

@article{16913873ff554653aad7007a5f6085e1,

title = "Reply to 'Rituximab in CD20 positive multiple myeloma' by P Moreau et al. [10]",

author = "Greipp, {P. T.} and P. Kapoor and Morice, {W. G.} and Witzig, {T. E.} and Greipp, {P. R.}",

year = "2008",

month = jan,

doi = "10.1038/sj.leu.2404972",

language = "English (US)",

volume = "22",

pages = "214--215",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Reply to 'Rituximab in CD20 positive multiple myeloma' by P Moreau et al. [10]

AU - Greipp, P. T.

AU - Kapoor, P.

AU - Morice, W. G.

AU - Witzig, T. E.

AU - Greipp, P. R.

PY - 2008/1

Y1 - 2008/1

UR - http://www.scopus.com/inward/record.url?scp=38349057298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349057298&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2404972

DO - 10.1038/sj.leu.2404972

M3 - Letter

C2 - 17928885

AN - SCOPUS:38349057298

SN - 0887-6924

VL - 22

SP - 214

EP - 215

JO - Leukemia

JF - Leukemia

IS - 1

ER -

Reply to 'Rituximab in CD20 positive multiple myeloma' by P Moreau et al. [10]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this